(Q33283676)

25 July 2017

title

Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet (English)

1 reference

25 July 2017

1 reference

1 reference

1 reference

7

B Ahrén

1 reference

25 July 2017

M Sörhede Winzell

1

1 reference

25 July 2017

C L Brand

2

1 reference

25 July 2017

N Wierup

3

1 reference

25 July 2017

U G Sidelmann

4

1 reference

25 July 2017

F Sundler

5

1 reference

25 July 2017

E Nishimura

6

1 reference

25 July 2017

publication date

4 May 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

50

1 reference

25 July 2017

issue

7

1 reference

25 July 2017

page(s)

1453-1462

1 reference

Glucagon and regulation of glucose metabolism

25 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-007-0675-3

Cocaine- and amphetamine-regulated transcript (CART) is expressed in several islet cell types during rat development

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-007-0675-3

Glucagon: Role in the Hyperglycemia of Diabetes Mellitus

21 January 2018

1 reference

12 December 2020

Glycemic control in mice with targeted disruption of the glucagon receptor gene

1 reference

12 December 2020

Beta-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology

1 reference

12 December 2020

The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects

1 reference

12 December 2020

Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice

1 reference

12 December 2020

Human glucagon receptor antagonists based on alkylidene hydrazides

1 reference

12 December 2020

Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis

1 reference

12 December 2020

A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects

1 reference

12 December 2020

Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice

1 reference

12 December 2020

Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon

1 reference

12 December 2020

Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.

1 reference

12 December 2020

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion

1 reference

12 December 2020

The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes

1 reference

12 December 2020

Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans

1 reference

12 December 2020

Impact of lack of suppression of glucagon on glucose tolerance in humans

1 reference

12 December 2020

A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.

1 reference

12 December 2020

Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

1 reference

12 December 2020

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice

1 reference

12 December 2020

Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance.

1 reference

12 December 2020

Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists

1 reference

12 December 2020

Relative contribution of glycogenolysis and gluconeogenesis to basal, glucagon- and nerve stimulation-dependent glucose output in the perfused liver from fed and fasted rats.

1 reference

12 December 2020

Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists

1 reference

12 December 2020

Effect of glucagon on glucose output from bivascularly perfused rat liver

1 reference

12 December 2020

Abnormal Pancreatic Glucagon Secretion and Postprandial Hyperglycemia In Diabetes Mellitus

1 reference

12 December 2020

Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice

1 reference

12 December 2020

The essential role of glucagon in the pathogenesis of diabetes mellitus

1 reference

12 December 2020

Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats

1 reference

12 December 2020

Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus

1 reference

12 December 2020

Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists

1 reference

12 December 2020

Role of glucagon in maintenance of euglycemia in fed and fasted rats.

1 reference

12 December 2020

Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women

1 reference

12 December 2020

Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function

1 reference

12 December 2020

Control of hepatic glucose output by glucagon and insulin in the intact dog

1 reference

12 December 2020

Glucagon as a target for the treatment of Type 2 diabetes

1 reference

12 December 2020

Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death.

1 reference

12 December 2020

Role of glucagon in the pathogenesis of diabetes: The status of the controversy

1 reference

12 December 2020

Glucagon receptors on human islet cells contribute to glucose competence of insulin release

1 reference

12 December 2020

Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians

1 reference

12 December 2020

Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics

1 reference

12 December 2020

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

1 reference

12 December 2020

Hyperglycemia of Diabetic Rats Decreased by a Glucagon Receptor Antagonist

1 reference

12 December 2020

beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.

1 reference

12 December 2020

Evidence for a Major Role for Glucagon in Regulation of Plasma Glucose in Conscious, Nondiabetic, and Alloxan-Induced Diabetic Rabbits

1 reference

12 December 2020

Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus

1 reference

12 December 2020

10.1007/S00125-007-0675-3

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1010783421

0 references

1 reference